| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |